Also trades as: PAR.AX (ASX) · $vol 0M
PBIGF OTC
Paradigm Biopharmaceuticals Limited
1W: -86.8%
1M: -98.9%
3M: -99.1%
YTD: -99.4%
1Y: -99.2%
3Y: -99.8%
5Y: -99.9%
$0.00
-0.00 (-17.65%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$44M
-172.8% ▼
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
-$44M
-172.8% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$613K
+38.9% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$39M | -$52M | -$59M | -$19M | -$56M |
| Depreciation & Amort. | $193K | $154K | $147K | $51K | $150K |
| Stock-Based Comp. | $3M | $936K | $0 | $0 | $0 |
| Change in Working Capital | $4M | $5M | -$9M | $98K | $8M |
| Other Non-Cash Items | -$1M | -$3M | $1M | $3M | $4M |
| Operating Cash Flow | -$32M | -$45M | -$66M | -$16M | -$44M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | $66M | $0 | -$490K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $11K |
| Investment Purchases | $0 | $0 | $0 | $0 | -$72K |
| Investment Sales | $0 | $0 | $0 | $46K | $0 |
| Other Investing | $0 | $0 | -$66M | $0 | $0 |
| Investing Cash Flow | $0 | $0 | $0 | $46K | -$552K |
| — Financing Activities — | |||||
| Net Debt Issuance | -$135K | $416K | -$102K | $0 | $23M |
| Stock Repurchased | $0 | -$4M | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $205K | -$104K | $0 | -$125K | -$132K |
| Financing Cash Flow | $70K | $63M | $28M | $15M | $44M |
| Net Change in Cash | -$31M | $17M | -$39M | -$1M | -$613K |
| Cash End of Period | $40M | $56M | $18M | $17M | $15M |
| Free Cash Flow | -$32M | -$45M | -$66M | -$16M | -$44M |